طاولة 1. قمة 100 المخدرات عن طريق المبيعات | ||
Rank | دواء (اسم العلامة التجارية) | المبيعات خلال شهر مارس 2014 |
1 | أبيليفاي | $6,885,243,368 |
2 | نيكسيوم | $6,271,376,299 |
3 | حميرا | $5,936,288,498 |
4 | كريستور | $5,502,148,010 |
5 | أدفير رمي القرص | $5,112,576,549 |
6 | إنبريل | $4,896,267,318 |
7 | ريميكاد | $4,235,535,358 |
8 | سيمبالتا | $4,095,537,942 |
9 | كوباكسون | $3,679,837,035 |
10 | نيولاستا | $3,634,919,067 |
11 | لانتوس سولوستار | $3,375,632,862 |
12 | Rituxan | $3,320,475,967 |
13 | Spiriva Handihaler | $3,140,602,715 |
14 | Januvia | $2,975,320,499 |
15 | Atripla | $2,894,627,347 |
16 | Lantus | $2,796,784,267 |
17 | Avastin | $2,742,284,655 |
18 | Lyrica | $2,611,451,728 |
19 | Oxycontin | $2,528,601,587 |
20 | Epogen | $2,346,224,521 |
21 | Celebrex | $2,342,549,444 |
22 | Truvada | $2,307,970,304 |
23 | Diovan | $2,190,542,692 |
24 | Gleevec | $1,995,042,989 |
25 | Herceptin | $1,971,724,243 |
26 | Lucentis | $1,917,919,037 |
27 | Namenda | $1,871,956,353 |
28 | Vyvanse | $1,848,814,801 |
29 | Zetia | $1,826,260,072 |
30 | Levemir | $1,775,037,064 |
31 | Symbicort | $1,733,830,589 |
32 | Sovaldi | $1,724,867,241 |
33 | Novolog Flexpen | $1,482,659,229 |
34 | Novolog | $1,409,680,368 |
35 | Tecfidera | $1,394,704,148 |
36 | Suboxone | $1,388,805,102 |
37 | Humalog | $1,310,236,982 |
38 | Xarelto | $1,263,697,546 |
39 | Seroquel XR | $1,251,615,894 |
40 | Viagra | $1,235,125,299 |
41 | Alimta | $1,205,717,422 |
42 | Victoza 3-Pak | $1,186,784,355 |
43 | Avonex | $1,184,476,004 |
44 | Nasonex | $1,180,165,756 |
45 | Cialis | $1,170,843,904 |
46 | Gilenya | $1,097,409,827 |
47 | Stelara | $1,083,660,282 |
48 | Flovent HFA | $1,078,422,967 |
49 | Prezista | $1,046,464,870 |
50 | Procrit | $1,037,298,436 |
51 | Isentress | $1,037,220,122 |
52 | Janumet | $1,028,179,032 |
53 | Renvela | $1,023,751,529 |
54 | Humalog Kwikpen | $1,003,100,788 |
55 | Orencia | $990,449,529 |
56 | Dexilant | $967,408,551 |
57 | Vesicare | $967,408,277 |
58 | Neupogen | $944,389,150 |
59 | Reyataz | $935,417,307 |
60 | Lunesta | $927,689,337 |
61 | Synthroid | $899,215,664 |
62 | Pradaxa | $862,604,444 |
63 | Zytiga | $861,683,197 |
64 | Benicar | $860,761,655 |
65 | Xolair | $859,052,353 |
66 | Avonex Pen | $849,256,894 |
67 | Vytorin | $846,602,646 |
68 | Invega Sustenna | $831,061,694 |
69 | Sensipar | $824,871,721 |
70 | Xgeva | $822,603,435 |
71 | Prevnar 13 | $821,372,081 |
72 | Evista | $815,315,970 |
73 | Aranesp | $814,017,366 |
74 | Betaseron | $792,093,855 |
75 | Stribild | $785,645,319 |
76 | Combivent Respimat | $768,925,543 |
77 | Xeloda | $761,832,629 |
78 | Afinitor | $761,796,538 |
79 | Ventolin HFA | $761,324,992 |
80 | Synagis | $755,220,544 |
81 | Zyvox | $732,206,096 |
82 | Bystolic | $719,917,435 |
83 | Sandostatin LAR | $708,264,105 |
84 | Complera | $696,270,123 |
85 | Benicar HCT | $692,128,910 |
86 | Treanda | $691,670,874 |
87 | Gardasil | $683,558,728 |
88 | Zostavax | $679,653,129 |
89 | Pristiq | $660,397,547 |
90 | Erbitux | $660,368,777 |
91 | Focalin XR | $647,720,027 |
92 | Tarceva | $646,108,218 |
93 | Cubicin | $643,649,546 |
94 | Strattera | $640,562,124 |
95 | Latuda | $639,903,393 |
96 | Velcade | $624,619,639 |
97 | Viread | $606,046,798 |
98 | Welchol | $603,644,260 |
99 | Nuvaring | $600,191,343 |
100 | Sprycel | $599,882,414 |
مصدر: IMS National Prescription Audit, IMS Health. |
العلاج بالخلايا الجذعية
العلاج بالخلايا الجذعية للكبد
يتعين على المرضى الذين يعانون من تليف الكبد اللا تعويضي في الغالب اختيار زراعة الكبد, لكن التوفر المحدود للأعضاء المانحة وارتفاع التكلفة يؤدي إلى ارتفاع معدل الوفيات في قائمة الانتظار . تساعد الخلايا الجذعية لجسم الفرد اقرأ المزيد…